|
See related Thyrogen powd for inj information |
|
|
|
Manufacturer |
Genzyme |
|
Distributor |
Berli Jucker |
|
Contents |
Thyrotropin α |
|
Indications |
Adjunctive treatment for radioiodine ablation of thyroid tissue remnants in patients who have undergone thyroidectomy for well-differentiated thyroid cancer. Adjunctive diagnostic tool for serum Tg testing w/ or w/o radioiodine imaging. |
|
Dosage |
2 inj regimen: 0.9 mg IM followed by a 2nd 0.9 mg IM 24 hr later. Radioiodine imaging or treatment Radioiodine should be administered 24 hr following the final Thyrogen inj. Serum Tg testing Serum sample should be obtained 72 hr after final inj of Thyrogen. |
|
Special Precautions |
Not recommended for patients w/ thyroid cancer who have not had a near total or total thyroidectomy. |
|
Adverse Drug Reactions |
Nausea & headache.
View ADR Monitoring Form |
|
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
|
Presentation/Packing |
|
Form |
Packing |
Photo |
|
Thyrogen powder for injection |
|
|
|
Manufacturer: |
Genzyme |
|
Distributor: |
Berli Jucker
|
|
|
|
